Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 23 Jun 2023

Immune microenvironment analysis and novel biomarkers of early-stage lung adenocarcinoma evolution

in Thoracic Oncology

Jun Liu
Yaxin Ji
Xiaodan Weng
Wei Shao
Jiaping Zhao
Hanlin Chen
Lu Shen
Fufeng Wang
Qi Meng
Xue Wu

Frontiers in Oncology

doi 10.3389/fonc.2023.1150098

3,821 views
6 citations

Editorial

Published on 22 Jun 2023

Editorial: Concomitant pathogenic mutations in oncogene-driven subgroups: when next generation biology meets targeted therapy in NSCLC

in Thoracic Oncology

Umberto Malapelle
Fabrizio Tabbò
Lucia Anna Muscarella

Frontiers in Oncology

doi 10.3389/fonc.2023.1239304

1,578 views
1 citation

Systematic Review

Published on 20 Jun 2023

Pathological complete response to long-course neoadjuvant alectinib in lung adenocarcinoma with EML4-ALK rearrangement: report of two cases and systematic review of case reports

in Thoracic Oncology

Liang Shi
Shuhong Gao
Li Tong
Qiyi Meng
Shijie Zhou
Daping Yu
Yujie Dong
Zhe Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1120511

3,979 views
7 citations

Original Research

Published on 20 Jun 2023

Factors associated with outcomes of second-line treatment for EGFR-mutant non-small-cell lung cancer patients after progression on first- or second-generation EGFR-tyrosine kinase inhibitor treatment

in Thoracic Oncology

Cheng-Yu Chang
Chung-Yu Chen
Shih-Chieh Chang
Ching-Yi Chen
Yi-Chun Lai
Chun-Fu Chang
Yu-Feng Wei

Frontiers in Oncology

doi 10.3389/fonc.2023.1104098

3,482 views
1 citation

Original Research

Published on 19 Jun 2023

Real-world outcomes of immunotherapy with or without chemotherapy in first-line treatment of advanced non-small cell lung cancer

in Thoracic Oncology

Veronika Pelicon
Tanja Cufer
Lea Knez

Frontiers in Oncology

doi 10.3389/fonc.2023.1182748

6,139 views
14 citations

Original Research

Published on 16 Jun 2023

Quantitative proteomics identifies tumour matrisome signatures in patients with non-small cell lung cancer

in Thoracic Oncology

Helen F. Titmarsh
Alex von Kriegsheim
Jimi C. Wills
Richard A. O’Connor
Kevin Dhaliwal
Margaret C. Frame
Samuel B. Pattle
David A. Dorward
Adam Byron
Ahsan R. Akram

Frontiers in Oncology

doi 10.3389/fonc.2023.1194515

5,000 views
8 citations

Editorial

Published on 16 Jun 2023

Editorial: Application of nanotechnology in diagnosis and/or therapy of non-small cell lung cancer

in Thoracic Oncology

Qinglin Shen
Ling Peng
Yi Zhang
Ruoxiang Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1234727

1,665 views
1 citation

Original Research

Published on 15 Jun 2023

A model-based head-to-head comparison of single-agent lurbinectedin in the pivotal ATLANTIS Study

in Thoracic Oncology

Salvador Fudio
Laura Pérez-Ramos
Eduardo Asín-Prieto
Ali Zeaiter
Rubin Lubomirov

Frontiers in Oncology

doi 10.3389/fonc.2023.1152371

3,538 views
5 citations

Correction

Published on 14 Jun 2023

Corrigendum: Efficacy of modified thoraco-laparoscopic Ivor-Lewis versus traditional thoraco-laparoscopic Ivor-Lewis for esophageal cancer: propensity score-matched analysis

in Thoracic Oncology

Ziqiang Hong
Wenxi Gou
Yingjie Lu
Xusheng Wu
Yannan Sheng
Baiqiang Cui
Xiangdou Bai
Dacheng Jin
Yunjiu Gou

Frontiers in Oncology

doi 10.3389/fonc.2023.1216836

1,403 views

Perspective

Published on 14 Jun 2023

Addressing the unmet need for a comprehensive lung cancer registry in Romania

in Thoracic Oncology

Gheorghe-Emilian Olteanu
Cristian Iulian Oancea
Marian Catalin
Adrian Pavel Trifa
Stefan Dascalu

Frontiers in Oncology

doi 10.3389/fonc.2023.1211533

3,476 views
3 citations

Original Research

Published on 12 Jun 2023

Prediction of distant organ metastasis and overall survival of lung cancer patients: a SEER population−based cohort study

in Thoracic Oncology

Yongping Hao
Guang Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1075385

5,959 views
6 citations

Original Research

Published on 09 Jun 2023

Etoposide/platinum plus anlotinib for patients with transformed small-cell lung cancer from EGFR-mutant lung adenocarcinoma after EGFR-TKI resistance: a retrospective and observational study

in Thoracic Oncology

Jianghua Ding
Zhaohui Leng
Hong Gu
Xiang Jing
Yun Song

Frontiers in Oncology

doi 10.3389/fonc.2023.1153131

3,441 views
14 citations

Original Research

Published on 08 Jun 2023

A nomogram combining thoracic CT and tumor markers to predict the malignant grade of pulmonary nodules ≤3 cm in diameter

in Thoracic Oncology

Jianhao Qiu
Rongyang Li
Yukai Wang
Xiuyuan Ma
Chenghao Qu
Binyan Liu
Weiming Yue
Hui Tian

Frontiers in Oncology

doi 10.3389/fonc.2023.1196883

3,070 views
1 citation

Editorial

Published on 07 Jun 2023

Editorial: Overcoming drug relapse and therapy resistance in NSCLC

in Thoracic Oncology

Sagun Parakh
Tracy L. Leong
Sarah A. Best
Ashleigh R. Poh

Frontiers in Oncology

doi 10.3389/fonc.2023.1230475

2,082 views
3 citations

Original Research

Published on 05 Jun 2023

Clinical features and prognosis of lung cancer in patients with connective tissue diseases: a retrospective cohort study

in Thoracic Oncology

Ningning Li
Liwei Gao
Chunmei Bai
Lin Zhao
Yajuan Shao

Frontiers in Oncology

doi 10.3389/fonc.2023.1167213

2,385 views
2 citations

Brief Research Report

Published on 02 Jun 2023

Diagnosis of primary lung cancer and benign pulmonary nodules: a comparison of the breath test and 18F-FDG PET-CT

in Thoracic Oncology

Xiangxiang Ding
Guihu Lin
Peiyu Wang
Haibin Chen
Nan Li
Zhi Yang
Mantang Qiu

Frontiers in Oncology

doi 10.3389/fonc.2023.1204435

3,449 views
8 citations

Original Research

Published on 31 May 2023

Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis

in Thoracic Oncology

Reem Altaf
Umair Ilyas
Anmei Ma
Meiqi Shi

Frontiers in Oncology

doi 10.3389/fonc.2023.1206768

6,248 views
6 citations

Original Research

Published on 24 May 2023

Neural network-based model for evaluating inert nodules and volume doubling time in T1 lung adenocarcinoma: a nested case−control study

in Thoracic Oncology

Bing Wang
Hui Zhang
Wei Li
Siyun Fu
Ye Li
Xiang Gao
Dongpo Wang
Xinjie Yang
Shaofa Xu
Jinghui Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1037052

2,396 views
2 citations

Original Research

Published on 24 May 2023

Analysis of bronchovascular patterns in the left superior division segment to explore the relationship between the descending bronchus and the artery crossing intersegmental planes

in Thoracic Oncology

Zhikai Li
Qingtao Zhao
Wenbo Wu
Zhonghui Hu
Xiaopeng Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1183227

1,977 views
2 citations

Mini Review

Published on 23 May 2023

Enhanced recovery of postoperative nursing for single-port thoracoscopic surgery in lung cancer patients

in Thoracic Oncology

Xiufen Hu
Xiaodan He

Frontiers in Oncology

doi 10.3389/fonc.2023.1163338

5,764 views
10 citations

Original Research

Published on 22 May 2023

EGFR and ERBB2 exon 20 insertion/duplication in advanced non–small cell lung cancer: genomic profiling and clinicopathologic features

in Thoracic Oncology

Ramakrishna R. Sompallae
Bilge Dundar
Natalya V. Guseva
Aaron D. Bossler
Deqin Ma

Frontiers in Oncology

doi 10.3389/fonc.2023.1163485

8,147 views
7 citations

Original Research

Published on 19 May 2023

Clinicopathological characteristics and cancer-specific prognosis of primary pulmonary lymphoepithelioma-like carcinoma: a population study of the US SEER database and a Chinese hospital

in Thoracic Oncology

Qun Zhang
Yuan Dai
Linling Jin
Shuangshuang Shi
Chang Liu
Rong Rong
Wenkui Sun
Shanlin Dai
Hui Kong
Weiping Xie

Frontiers in Oncology

doi 10.3389/fonc.2023.1103169

3,770 views
5 citations

Case Report

Published on 18 May 2023

Case Report: Complete pathologic response to neoadjuvant selpercatinib in a patient with resectable early-stage RET fusion-positive non-small cell lung cancer

in Thoracic Oncology

Jonathan W. Goldman
Lynette M. Sholl
Sanja Dacic
Michael C. Fishbein
Yonina R. Murciano-Goroff
Ravi Rajaram
Sylwia Szymczak
Anna M. Szpurka
Bo H. Chao
Alexander Drilon

Frontiers in Oncology

doi 10.3389/fonc.2023.1178313

5,306 views
5 citations

Review

Published on 17 May 2023

Advances in efficacy prediction and monitoring of neoadjuvant immunotherapy for non-small cell lung cancer

in Thoracic Oncology

Yunzhen Wang
Sha Huang
Xiangwei Feng
Wangjue Xu
Raojun Luo
Ziyi Zhu
Qingxin Zeng
Zhengfu He

Frontiers in Oncology

doi 10.3389/fonc.2023.1145128

7,725 views
14 citations

1,929 articles

articles

Immune microenvironment analysis and novel biomarkers of early-stage lung adenocarcinoma evolution

Editorial: Concomitant pathogenic mutations in oncogene-driven subgroups: when next generation biology meets targeted therapy in NSCLC

Pathological complete response to long-course neoadjuvant alectinib in lung adenocarcinoma with EML4-ALK rearrangement: report of two cases and systematic review of case reports

Factors associated with outcomes of second-line treatment for EGFR-mutant non-small-cell lung cancer patients after progression on first- or second-generation EGFR-tyrosine kinase inhibitor treatment

Real-world outcomes of immunotherapy with or without chemotherapy in first-line treatment of advanced non-small cell lung cancer

Quantitative proteomics identifies tumour matrisome signatures in patients with non-small cell lung cancer

Editorial: Application of nanotechnology in diagnosis and/or therapy of non-small cell lung cancer

A model-based head-to-head comparison of single-agent lurbinectedin in the pivotal ATLANTIS Study

Corrigendum: Efficacy of modified thoraco-laparoscopic Ivor-Lewis versus traditional thoraco-laparoscopic Ivor-Lewis for esophageal cancer: propensity score-matched analysis

Addressing the unmet need for a comprehensive lung cancer registry in Romania

Prediction of distant organ metastasis and overall survival of lung cancer patients: a SEER population−based cohort study

Etoposide/platinum plus anlotinib for patients with transformed small-cell lung cancer from EGFR-mutant lung adenocarcinoma after EGFR-TKI resistance: a retrospective and observational study

A nomogram combining thoracic CT and tumor markers to predict the malignant grade of pulmonary nodules ≤3 cm in diameter

Editorial: Overcoming drug relapse and therapy resistance in NSCLC

Clinical features and prognosis of lung cancer in patients with connective tissue diseases: a retrospective cohort study

Diagnosis of primary lung cancer and benign pulmonary nodules: a comparison of the breath test and 18F-FDG PET-CT

Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis

Neural network-based model for evaluating inert nodules and volume doubling time in T1 lung adenocarcinoma: a nested case−control study

Analysis of bronchovascular patterns in the left superior division segment to explore the relationship between the descending bronchus and the artery crossing intersegmental planes

Enhanced recovery of postoperative nursing for single-port thoracoscopic surgery in lung cancer patients

EGFR and ERBB2 exon 20 insertion/duplication in advanced non–small cell lung cancer: genomic profiling and clinicopathologic features

Clinicopathological characteristics and cancer-specific prognosis of primary pulmonary lymphoepithelioma-like carcinoma: a population study of the US SEER database and a Chinese hospital

Case Report: Complete pathologic response to neoadjuvant selpercatinib in a patient with resectable early-stage RET fusion-positive non-small cell lung cancer

Advances in efficacy prediction and monitoring of neoadjuvant immunotherapy for non-small cell lung cancer